0001235802-19-000129.txt : 20191015
0001235802-19-000129.hdr.sgml : 20191015
20191015162346
ACCESSION NUMBER: 0001235802-19-000129
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191015
FILED AS OF DATE: 20191015
DATE AS OF CHANGE: 20191015
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Browne Sean E
CENTRAL INDEX KEY: 0001790461
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34951
FILM NUMBER: 191151187
MAIL ADDRESS:
STREET 1: 664 CRUISER LANE
CITY: BELGRADE
STATE: MT
ZIP: 59714
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xtant Medical Holdings, Inc.
CENTRAL INDEX KEY: 0001453593
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 205313323
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 664 CRUISER LANE
CITY: BELGRADE
STATE: MT
ZIP: 59714
BUSINESS PHONE: 406-388-0480
MAIL ADDRESS:
STREET 1: 664 CRUISER LANE
CITY: BELGRADE
STATE: MT
ZIP: 59714
FORMER COMPANY:
FORMER CONFORMED NAME: Bacterin International Holdings, Inc.
DATE OF NAME CHANGE: 20100615
FORMER COMPANY:
FORMER CONFORMED NAME: K KITZ INC
DATE OF NAME CHANGE: 20090108
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2019-10-15
0
0001453593
Xtant Medical Holdings, Inc.
XTNT
0001790461
Browne Sean E
664 CRUISER LANE
BELGRADE
MT
59714
0
1
0
0
President and CEO
Common Stock, $0.000001 par value
2019-10-15
4
A
0
329044
0
A
329044
D
Stock Option
2.7
2019-10-15
4
A
0
329044
0
A
2029-10-15
Common Stock
329044
329044
D
These shares will vest and be issued with respect to 65,809 shares on each of October 15, 2020, October 15, 2021, October 15, 2022 and October 15, 2023 and with respect to 65,808 shares on October 15, 2024 pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, conditioned upon the reporting person remaining an employee of Xtant through the vesting date.
This option vests with respect to 65,809 shares on each of October 15, 2020, October 15, 2021, October 15, 2022 and October 15, 2023 and with respect to 65,808 shares on October 15, 2024 pursuant to an option award granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, conditioned upon the reporting person remaining an employee of Xtant through the vesting date.
/s/ Sean E. Browne
2019-10-15